(2024)
Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT
Promoter Mutation.
KOREAN JOURNAL OF RADIOLOGY.
25,
1
(2023)
Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
PLOS ONE.
18,
11
(2023)
Mortality rate and causes of death in papillary thyroid microcarcinoma.
ENDOCRINE.
-,
-
(2023)
Preoperative identification of low‑risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
SCIENTIFIC REPORTS.
13,
1
(2023)
Comparison of clinicopathological characteristics and survival between symptomatic and asymptomatic anaplastic thyroid carcinoma.
SCIENTIFIC REPORTS.
13,
1
(2023)
Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status.
ANNALS OF SURGICAL ONCOLOGY.
-,
-
(2023)
Dyslipidemia Is a Risk Factor for Hypothyroidism in Women: A Longitudinal Cohort Study from South Korea.
THYROID.
33,
1
(2022)
Identification of Mutations in the Thyroxine-Binding Globulin (TBG) Gene in Patients with TBG Deficiency in Korea.
ENDOCRINOLOGY AND METABOLISM.
37,
6
(2022)
The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy.
EPILEPSIA.
63,
12
(2022)
Graves' disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study.
FRONTIERS IN ENDOCRINOLOGY.
13,
-
(2022)
Ultrasonographic characteristics of H?rthle cell neoplasms: prediction of malignancy.
ULTRASONOGRAPHY.
41,
4
(2022)
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients.
ENDOCRINOLOGY AND METABOLISM.
37,
4
(2022)
Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy.
CLINICAL ENDOCRINOLOGY.
97,
1
(2022)
What is the difference between the tall cell variant and the classic type of papillary thyroid carcinoma on ultrasonography?.
ULTRASONOGRAPHY.
41,
3
(2022)
Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
JOURNAL OF PEDIATRIC SURGERY.
-,
-
(2022)
Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women.
ENDOCRINOLOGY AND METABOLISM.
37,
3
(2022)
Graves' Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study.
ENDOCRINOLOGY AND METABOLISM.
37,
2
(2022)
Smoking, alcohol consumption, and the risk of thyroid cancer: a population‐based Korean cohort study of 23 million people.
THYROID.
--,
-
(2022)
Effect of TSH levels during active surveillance of PTMC according to age.
ENDOCRINE-RELATED CANCER.
29,
4
(2022)
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations.
MODERN PATHOLOGY.
35,
2
Patent/Intellectual Property
AHR 분류에 기반한 갑상선암 예후 예측 방법 및 시스템.
10-2017-0097579.
20200219.
KOREA, REPUBLIC OF
Conference Paper
(2023)
임신 중 갑상선 질환의 진단과 치료.
2023 성균관의대 삼성서울병원 산부인과 연수강좌.
KOREA, REPUBLIC OF
(2023)
임신 전 후 갑상선 기능 이상의 관리 비법.
대한내분비학회 제 57회 연수강좌.
KOREA, REPUBLIC OF
(2023)
Association between thyroid hormones within normal to subclinical dysfunction and left ventricular diastolic dysfunction.
afes2023thailand.
THAILAND
(2023)
Initial clinical outcomes of papillary thyroid cancer with TERT promoter mutation from real world data.
SICEM 2023.
KOREA, REPUBLIC OF
(2023)
Hypothyroidism without elevation of thyroid-sttmulating hormone associated with oxcarbazepine use in children and adolescents.
ESPE 2023.
NETHERLANDS
(2023)
Association between BMI and Brafv600E mutation status may differ by primary tumor size.
45th Annual Meeting of the European Thyroid Association.
ITALY
(2023)
Can tert promoter mutation be a poor prognostic factor in undifferentiated thyroid carcinoma?.
45th Annual Meeting of the European Thyroid Association.
ITALY
(2023)
Diagnostic performance of 18E-choline PET/CT for detection of hyperfunctioning parathyroid glands in patients with primary hyperparathyroidism: a single-center experience.
45th Annual Meeting of the European Thyroid Association.
ITALY
(2023)
Clinical manifestations of malignant stma ovarii in a tertiary hospital in Korea.
2023년 대한갑상선학회 추계 학술대회.
KOREA, REPUBLIC OF
(2023)
The association between BMI and BRAFV600E mutation status may differ by primary tumor size.
2023년 대한갑상선학회 추계학술대회.
KOREA, REPUBLIC OF
(2023)
Initial clinical outcmes of papillary thyroid cancer with with TERT promoter mutation from real world data.
2023년 대한갑상선학회 추계예술대회.
KOREA, REPUBLIC OF
(2023)
Change In The Clinicopathological Characteristics And Outcomes Of Pediatric Thyroid Carcinoma In Korea : Focusing On Data From A Teritary Hospital In Korea.
ENDO 2023.
UNITED STATES
(2023)
Association between BMI and BRAF mutational status may differ by primary tumor size.
ENDOCRINOLOGY AND METBOLISM.
KOREA, REPUBLIC OF
(2020)
ATD and Pregnancy - What We Know about Adverse Effect 2.
16TH INTERNATIONAL THYROID CONGRESS.
CHINA
(2020)
CLINICAL COURSE FROM DIAGNOSIS TO DEATH IN PATIENTS WITH DIFFERENTIATED.
AOCE-SICEM 2020.
KOREA, REPUBLIC OF
(2020)
Breast cancer metastasized to thyroid which was misread as papillary carcinoma.
2020년 제71차 대한내과학회 추계학술대회.
KOREA, REPUBLIC OF
(2020)
Adequate levothyroxine dose for TSH suppression in differentiated thyroid cancer patients after total thyroidectomy.
2020년 대한갑상선학회 추계학술대회.
KOREA, REPUBLIC OF
(2020)
Bone meneral density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients with TSH suppression therapy.
2020년 대한갑상선학회 추계학술대회.
KOREA, REPUBLIC OF
(2020)
Changes in the levels of thyrotropin binding inhibitory immunoglobulins following total thyroidectomy or radioiodine therapy in patients with refractory Graves' disease.
2020년 대한갑상선학회 추계학술대회.
KOREA, REPUBLIC OF